• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,675.18 842.63
( 1.14%)
Global Indices
Nasdaq
50,865.93 926.15
(1.85%)
Dow Jones
7,414.60 126.61
(1.74%)
Hang Seng
64,050.08 -129.19
(-0.20%)
Nikkei 225
10,316.43 61.62
(0.60%)
Forex
USD-INR
95.34 -0.07
(-0.08%)
EUR-INR
110.08 -0.10
(-0.09%)
GBP-INR
127.59 -0.01
(-0.01%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Vertex Securities Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
531950
INE316D01024
0.9758444
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
34.64
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

skipper ltd
Concord Biotech receives USFDA approval for Mycophenolate Mofetil for Oral Suspension USP
Jun 02,2026
Concord Biotech has received approval from the U.S. Food and Drug Administration (USFDA) for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants.